Allergan Receives U.S. Food And Drug Administration Approval For TRIVARIS? (triamcinolone Acetonide Injectable Suspension) 80 Mg/mL
Allergan, Inc. (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved TRIVARIS? (triamcinolone acetonide injectable suspension) 80 mg/mL, a synthetic glucocorticoid corticosteroid with anti-inflammatory action. Delivered via intravitreal injection, the ophthalmic indications for TRIVARIS? include sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Omega-3 Fatty Acids Linked To Prevention Of Macular Degeneration
Researchers have more good news for those who enjoy eating fish. Ameta-analysis published in the June issue of Archives ofOphthalmology found that consumption of foods high in omega-3fatty acids, such as fish and flax, is linked to a reductionin the risk of age-related macular degeneration (AMD) - a common eyedisease. However, the authors indicate a need for more clinical trialsbefore they can advocate routineconsumption of these foods for the prevention of AMD.
